In collaboration with Imperial College Healthcare in London and the Regional Clinical Hospital of Ivano-Frankivsk in Ukraine, an ongoing study evaluated BioWave's non-invasive neuromodulation ...
Shares of Artelo Biosciences rose after the company reported positive data for its first in-human trial for a potential non-opioid treatment for persistent pain. The stock more than doubled to $16.30 ...
Tonix Pharmaceuticals (NASDAQ:TNXP) added ~10% on Thursday after the company announced peer-reviewed data from a Phase 3 trial for its pain therapy candidate TNX-102 SL, and new findings related to ...
WEST HARTFORD, Conn., Sept. 2, 2025 /PRNewswire/ -- Chronic pain is not just a code in a chart or a number on a pain scale—it's a life-altering, deeply distressing experience. More than 1 in 4 ...
The CHLA-developed app will collect data for future research in machine learning to detect sleep disorders and help advance the standards of pediatric care in pain and sleep medicine Children’s ...
On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.
– Positive results from ALLEVIATE-1 Phase 3 pivotal trial for cebranopadol which demonstrates statistically significant pain reduction compared to placebo in patients after abdominoplasty will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback